Skip to main content

Table 5 Percent of patients with increased PA-level (Δ-value) at 6-month follow-up, analysed with 1–2 baseline predictive correlates

From: Which patients benefit from physical activity on prescription (PAP)? A prospective observational analysis of factors that predict increased physical activity

Correlate of PA (n)

Increased PA-level (∆ value)

% of patients

p valuea

phi coefficient

Positive values

Negative values

  

SEE (170/155)

74.1

72.9

0.804

0.01

PREP (183/164)

77.0

70.7

0.180

0.07

CONF (179/167)

79.9

67.7

0.010

0.14

BMI (130/226)

81.5

71.2

0.031

0.12

PCS (181/162)

79.0

68.5

0.027

0.12

SEE/PREP (109/92)

79.8

75.0

0.414

0.06

SEE/CONF (106/94)

79.2

69.1

0.102

0.12

SEE/BMI (69/106)

82.6

69.8

0.057

0.14

SEE/PCS (95/79)

80.0

69.6

0.114

0.12

PREP/CONF (128/112)

79.7

66.1

0.017

0.15

PREP/BMI (62/100)

79.0

64.0

0.043

0.16

PREP/PCS (101/80)

83.2

67.5

0.014

0.18

CONF/BMI (64/105)

82.8

69.1

0.004

0.22

CONF/PCS (102/85)

88.2

68.2

0.001

0.24

BMI/PCS (77/113)

84.4

65.5

0.004

0.21

 

Low values

High values

  

PABL (152/119)

84.0

66.1

< 0.001

0.21

  1. PA-level physical activity level according to ACSM/AHA questionnaire, SEE self-efficacy expectations, PREP readiness to change – prepared, CONF readiness to change – confident, BMI body max index, PCS physical component summary – SF-36, PABL physical activity at baseline
  2. Cut-points regarding positively assessed values were: SEE ≥4.77 points, PREP > 86 mm, CONF > 68 mm, BMI < 30, PCS ≥ 47.06 points. Cut-point regarding low PABL was < 2 points
  3. aP values were determined by Chi-square test for independence
  4. Statistical significance was set at p ≤ 0.05. Statistical significant p-values are presented in bold numbers